RNAZ ▲ +6.8% - TransCode Therapeutics, Inc. $RNAZ RNAZ - TransCode Therapeutics Announces Patent Advancements in Australia and Japan Strengthening Global IP Position in RNA-Based Immuno-Oncology TransCode Therapeutics shares rose 6.8% following the company's announcement of patent advancements in Australia and Japan, which strengthen its intellectual property position in RNA-based immuno-oncology. The expanded patent protection in key markets bolsters TransCode's ability to defend its technology platform and commercial potential in the competitive oncology space. 22-SEP-2026 08:04 AM ET